Continuous subcutaneous infusion of Remodulin™, a prostacyclin analogue, in patients with pulmonary arterial hypertension:: Long-term outcome

被引：0
|
作者：
McLaughlin, V
Sitbon, O
Sigman, J
Blackburn, S
机构：
[1] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
[2] Hop Antoine Beclere, Clamart, France
[3] United Therapeut Corp, Res Triangle Pk, NC USA
[4] United Therapeut Corp, Remodulin Study Grp, Res Triangle Pk, NC USA
来源：
CIRCULATION | 2001年 / 104卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1203
引用
收藏
页码：250 / 250
页数：1
相关论文
共 50 条
  • [31] Long-term outcomes in pulmonary arterial hypertension
    Thenappan, T.
    Palevsky, H. I.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 : 42 - 44
  • [32] Pregnancy outcome in patients with pulmonary arterial hypertension receiving prostacyclin therapy
    Bendayan, D
    Hod, M
    Oron, G
    Sagie, A
    Eidelman, L
    Shitrit, D
    Kramer, MR
    OBSTETRICS AND GYNECOLOGY, 2005, 106 (05): : 1206 - 1210
  • [33] Impact of additional selexipag on prostacyclin infusion analogs in patients with pulmonary arterial hypertension
    Momoi, Mizuki
    Hiraide, Takahiro
    Shinya, Yoshiki
    Momota, Hiromi
    Fukui, Shogo
    Kawakami, Michiyuki
    Fukuda, Keiichi
    Kataoka, Masaharu
    RESPIRATORY MEDICINE CASE REPORTS, 2022, 36
  • [34] LONG-TERM CONTINUOUS INTRAVENOUS PROSTACYCLIN IMPROVES SURVIVAL IN CHILDREN WITH PRIMARY PULMONARY-HYPERTENSION
    BARST, RJ
    KERSTEIN, D
    KIRKPATRICK, J
    BLACKBURN, SD
    LEVY, PS
    CIRCULATION, 1995, 92 (08) : 593 - 593
  • [35] LONG-TERM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN DIABETICS AT HOME
    PICKUP, JC
    WHITE, MC
    KEEN, H
    PARSONS, JA
    ALBERTI, KGMM
    LANCET, 1979, 2 (8148): : 870 - 873
  • [36] Patient management of long-term continuous subcutaneous insulin infusion
    Johansson, UB
    Adamson, U
    Lins, PE
    Wredling, R
    JOURNAL OF ADVANCED NURSING, 2005, 51 (02) : 112 - 118
  • [37] Long-term prostacyclin infusion to reduce pulmonary hypertension in a pediatric cardiac transplant candidate prior to transplantation
    Kao, B
    Balzer, DT
    Huddleston, CB
    Canter, CE
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (07): : 785 - 788
  • [38] Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases
    Girgis, RE
    Mathai, SC
    Krishnan, JA
    Wigley, FM
    Hassoun, PM
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (10): : 1626 - 1631
  • [39] Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension
    Stiebellehner, L
    Petkov, V
    Vonbank, K
    Funk, G
    Schenk, P
    Ziesche, R
    Block, LH
    CHEST, 2003, 123 (04) : 1293 - 1295
  • [40] Long-Term Hepatic Safety of Ambrisentan in Patients With Pulmonary Arterial Hypertension
    Ben-Yehuda, Ori
    Pizzuti, David
    Brown, Andrea
    Littman, Marcus
    Gillies, Hunter
    Henig, Noreen
    Peschel, Tobias
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (01) : 80 - U105
12345